Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stomach cancer: multimodality therapy--reliable and new developments].

P M Schlag1

  • 1Chirurgische Universitäts-Klinik Heidelberg.

Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|January 1, 1992
PubMed
Summary

Adjuvant chemotherapy shows limited benefit for gastric cancer in Western trials, unlike Japanese studies. Timing and method of drug delivery, particularly intraperitoneal or intraoperative therapy, may explain these differences and improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.

Oncogene·2015
Same author

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.

European journal of cancer (Oxford, England : 1990)·2014
Same author

Contrast features of breast cancer in frequency-domain laser scanning mammography.

Journal of biomedical optics·2012
Same author

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells.

British journal of cancer·2012
Same author

Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.

Gene therapy·2011
Same author

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Zeitschrift fur Gastroenterologie·2011

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastrointestinal Oncology

Context:

  • Surgical radicality and multivisceral resections offer limited prognostic improvement in gastric cancer.
  • Adjuvant chemotherapy has shown inconsistent efficacy across different geographical regions, notably between Western and Japanese trials.
  • Investigating novel therapeutic strategies is crucial for enhancing gastric cancer treatment outcomes.

Purpose:

  • To explore the discrepancies in adjuvant chemotherapy efficacy for gastric cancer between Western and Japanese studies.
  • To identify potential factors influencing chemotherapy effectiveness, such as timing and administration route.
  • To evaluate the potential of neoadjuvant chemotherapy, intraoperative radiation, and photodynamic therapy in gastric cancer management.

Summary:

Related Experiment Videos

  • Western studies indicate that adjuvant chemotherapy does not significantly improve gastric cancer prognosis, contrasting with findings from Japanese trials.
  • Differences in the timing and mode of drug application, including immediate post- or intraoperative and intraperitoneal therapy, may account for these observed discrepancies.
  • Preoperative chemotherapy has shown promise in improving resectability rates in some phase II trials, warranting further investigation for broader applicability.

Impact:

  • Highlights the need for further research into optimizing chemotherapy delivery for gastric cancer.
  • Suggests that intraoperative radiation (IORT) and photodynamic therapy (PDT) may represent future advancements in gastric cancer treatment.
  • Emphasizes the importance of considering regional variations and therapeutic modalities in designing gastric cancer treatment protocols.